Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure
By B. Rochwerg, L. Brochard, M. Elliott, D. Hess, N. Hill, S. Nava, P. Navalesi, M. Antonelli, J. Brożek, G. Conti and 7 more. European Respiratory Journal, 2017
1,293 citations recorded by the source corpus.
Noninvasive mechanical ventilation (NIV) is widely used in the acute care setting for acute respiratory failure (ARF) across a variety of aetiologies. This document provides European Respiratory Society/American Thoracic Society recommendations for the clinical application of NIV based on the most current literature. The guideline committee was composed of clinicians, methodologists and experts in the field of NIV. The committee developed recommendations based on the GRADE (Grading, Recommendation, Assessment, Development and Evaluation) methodology for each actionable question. The GRADE Evidence to Decision framework in the guideline development tool was used to generate recommendations. A number of topics were addressed using technical summaries without recommendations and these are discussed in the supplementary material. This guideline committee developed recommendations for 11 actionable questions in a PICO (population–intervention–comparison–outcome) format, all addressing the use of NIV for various aetiologies of ARF. The specific conditions where recommendations were made include exacerbation of chronic obstructive pulmonary disease, cardiogenic pulmonary oedema, de novo hypoxaemic respiratory failure, immunocompromised patients, chest trauma, palliation, post-operative care, weaning and post-extubation. This document summarises the current state of knowledge regarding the role of NIV in ARF. Evidence-based recommendations provide guidance to relevant stakeholders. ERS/ATS evidence-based recommendations for the use of noninvasive ventilation in acute respiratory failure http://ow.ly/NrqB30dAYSQ
Subfields: Critical Care and Intensive Care Medicine, Emergency Medicine, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/271e5602f4e41d51690c5e7a2a733d9120df07bd
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Critical Care and Intensive Care Medicine
In Emergency Medicine
In Pulmonary and Respiratory Medicine
Citations in the corpus
- ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies (2023, background): “Background Non-invasive ventilation improves outcomes and has been recommended for patients with acute hypercapnic respiratory failure from acute exacerbations of COPD or patients with cardiogenic pulmonary edema [68].”
- Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. Interim guidance (2020, background): “Patients with hypercapnia (exacerbation of obstructive lung disease, cardiogenic pulmonary oedema), hemodynamic instability, multiorgan failure, or abnormal mental status should generally not receive HFNO, although emerging data suggest that HFNO may be safe in patients with mild-moderate and non-wo”
- Coronavirus Diseases (COVID-19) Current Status and Future Perspectives: A Narrative Review (2020, background): “Mechanical ventilation is the main supportive treatment for critically ill patients [54,55].”
- Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19) (2020, background): “If, in certain COVID-19 patients, other forms of respiratory failure, such as acute hypercapnic respiratory failure or acute cardiogenic pulmonary edema, are known to be the cause of respiratory failure, NIPPV may be beneficial (88, 89) .”